INT47483

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.34
First Reported 1980
Last Reported 2010
Negated 1
Speculated 0
Reported most in Body
Documents 4
Total Number 4
Disease Relevance 0.32
Pain Relevance 0.07

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (CSH1) extracellular region (CSH1)
Anatomy Link Frequency
VMO 2
skin 2
CSH1 (Homo sapiens)
Pain Link Frequency Relevance Heat
Dismenorea 2 65.16 Quite High
Patellofemoral syndrome 2 50.00 Quite Low
Botox 4 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
Potency 1 5.00 Very Low Very Low Very Low
imagery 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Wrinkles 13 66.72 Quite High
Pigment Disorder 1 65.76 Quite High
Dysmenorrhea 2 65.16 Quite High
Reprotox - General 3 2 64.00 Quite High
Galactorrhea 2 61.36 Quite High
Patellofemoral Pain Syndrome 2 50.00 Quite Low
Aging 19 43.24 Quite Low
Cicatrix 6 42.96 Quite Low
Acne 6 42.72 Quite Low
Disease 1 17.24 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
To study the role of PRL in the regulation of the production of 17 beta-estradiol, progesterone, testosterone, and human placental lactogen (hPL), 11 healthy women were given 150 mg sulpiride daily for 14 days, beginning between weeks 6--9 of normal gestation.
Regulation (regulation) of Gene_expression (production) of placental lactogen
1) Confidence 0.34 Published 1980 Journal J. Clin. Endocrinol. Metab. Section Abstract Doc Link 7380989 Disease Relevance 0 Pain Relevance 0
Sulpiride treatment during early human pregnancy: effect on the levels of prolactin, six steroids, and placental lactogen.
Regulation (effect) of Gene_expression (levels) of placental lactogen
2) Confidence 0.18 Published 1980 Journal J. Clin. Endocrinol. Metab. Section Title Doc Link 7380989 Disease Relevance 0.19 Pain Relevance 0.07
RESULTS: Significant improvements in VAS-W ratings, Lysholm scale scores, and VMO CSA and volume were observed after the intervention in both exercise groups, but not in the control group.
Neg (not) Regulation (were) of Gene_expression (improvements) of CSA in VMO
3) Confidence 0.07 Published 2009 Journal Phys Ther Section Body Doc Link 19299508 Disease Relevance 0 Pain Relevance 0
A lipophilized ester-derivative of salicylic acid, capryloyl salicylic acid (CSA), has been shown to be an effective exfoliating agent due to its reduced penetration in the skin.34
Regulation (derivative) of Gene_expression (shown) of CSA in skin
4) Confidence 0.04 Published 2010 Journal Clin Interv Aging Section Body Doc Link PMC2946856 Disease Relevance 0.13 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox